Literature DB >> 16393352

Leishmanolysin (gp63 metallopeptidase)-like activity extracellularly released by Herpetomonas samuelpessoai.

C G R Elias1, F M Pereira, B A Silva, C S Alviano, R M A Soares, A L S Santos.   

Abstract

In previous studies, we showed that Herpetomonas samuelpessoai produced a large amount of a surface-located metallopeptidase that presented similar biochemical properties to that of gp63 from Leishmania spp., which is a well-known virulence factor expressed by these digenetic parasites. The present study aims to identify the proteolytic activity released by living H. samuelpessoai cells. In this context, the parasites were incubated in phosphate buffer up to 4 h, and the supernatants were obtained by centrifugation and filtration steps and were then applied on SDS-PAGE to determine the secretory protein profile and on gelatin-SDS-PAGE to identify the proteolytic activity. The results demonstrated that H. samuelpessoai secreted at least 12 polypeptides and an extracellular peptidase of 66 kDa. This enzyme had its activity diminished by 1,10-phenanthroline, EDTA and EGTA. This metallopeptidase was active in a broad spectrum of pH, showing maximum activity at pH 6.0 at 37 degrees C. Casein was also cleaved by this secretory proteolytic enzyme, while bovine serum albumin and haemoglobin were not degraded under these conditions. Fluorescence microscopy and flow cytometry using anti-gp63 antibody against leishmanolysin of L. amazonensis demonstrated the presence of similar molecules on the cell-surface of H. samuelpessoai. Moreover, immunoblot analysis showed the presence of a reactive polypeptide in the cellular extract and in the supernatant fluid of H. samuelpessoai, which suggests immunological similarities between these two distinct trypanosomatids. The zinc-metallopeptidase inhibitor 1,10-phenanthroline was able to inhibit the secretion of the 66 kDa metallopeptidase in a dose-dependent manner, while the phospholipase C inhibitor (p-CMPS) did not alter the secretion pattern. Additionally, anti-cross-reacting determinant (CRD) antibody failed to recognize any secreted polypeptide from H. samuelpessoai. Collectively, these results suggest that the gp63-like molecule was released from the H. samuelpessoai surface by proteolysis instead of phospholipolysis, in a similar mechanism to that observed in Leishmania.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393352     DOI: 10.1017/S0031182005008802

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  5 in total

1.  Internal and surface-localized major surface proteases of Leishmania spp. and their differential release from promastigotes.

Authors:  Chaoqun Yao; John E Donelson; Mary E Wilson
Journal:  Eukaryot Cell       Date:  2007-08-10

2.  Differential influence of gp63-like molecules in three distinct Leptomonas species on the adhesion to insect cells.

Authors:  F M Pereira; P S Bernardo; P F F Dias Junior; B A Silva; M T V Romanos; C M d'Avila-Levy; M H Branquinha; A L S Santos
Journal:  Parasitol Res       Date:  2008-10-01       Impact factor: 2.289

3.  Comparative in-silico genome analysis of Leishmania (Leishmania) donovani: A step towards its species specificity.

Authors:  Satheesh Kumar S; Gokulasuriyan R K; Monidipa Ghosh
Journal:  Meta Gene       Date:  2014-10-24

4.  Analysis of Peptidases in Non-Infected and Trypanosoma cruzi-Infected Mouse Embryo Hepatocyte Cells.

Authors:  Ana Cristina Nogueira de Melo; André Luis Souza Dos Santos; Maria Nazareth Leal Meirelles; Marta Helena Branquinha; Alane Beatriz Vermelho
Journal:  Int J Biomed Sci       Date:  2008-06

5.  RNA-seq-based metatranscriptomic and microscopic investigation reveals novel metalloproteases of Neobodo sp. as potential virulence factors for soft tunic syndrome in Halocynthia roretzi.

Authors:  Ho Bin Jang; Young Kyu Kim; Carmelo S Del Castillo; Seong Won Nho; In Seok Cha; Seong Bin Park; Mi Ae Ha; Jun-Ichi Hikima; Sung Jong Hong; Takashi Aoki; Tae Sung Jung
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.